VHCP Management III’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

VHCP Management III’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$119M	Buy	2,516,242 +2,449,575	+3,674%	+$70.7M	23.54%	2
2019 Q3	$431K	Hold	66,667	–	–	0.27%	15
2019 Q2	$819K	Hold	66,667	–	–	0.38%	15
2019 Q1	$903K	Hold	66,667	–	–	0.53%	16
2018 Q4	$267K	Hold	66,667	–	–	0.19%	15
2018 Q3	$449K	Buy	+66,667	New	+$635K	0.34%	13

Other funds holding CNST

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ROTUOC

Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

VHCP Management III's CNST Position: Q4 2019 in Review

VHCP Management III increased its Constellation Pharmaceuticals, Inc. (CNST) stake by 3,674% in Q4 2019, buying an estimated $70.7M and bringing the position to 2,516,242 shares worth $119M. The position accounts for 23.54% of the portfolio, ranked #2.

VHCP Management III first reported a position in CNST in Q3 2018 and has held it in 6 quarters since. 100 funds tracked by Wall St. Rank hold CNST as of Q4 2019.

VHCP Management III held 2,516,242 shares of Constellation Pharmaceuticals, Inc. worth $119M as of Q4 2019.
VHCP Management III bought 2,449,575 Constellation Pharmaceuticals, Inc. shares in Q4 2019, an estimated $70.7M.
Constellation Pharmaceuticals, Inc. made up 23.54% of VHCP Management III's portfolio in Q4 2019, its #2 holding.
VHCP Management III first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and has held it in 6 quarters since.
100 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.